Allspring Global Investments
CLVS

Allspring Global Investments’s Clovis Oncology, Inc. CLVS Stock Holding History

Allspring Global Investments’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-26,156
Closed -$31K – 2974
2022
Q3 		$31K Buy
26,156
+7,961
+44% +$12.4K ﹤0.01% 2514
2022
Q2 		$32K Sell
18,195
-32,149
-64% -$47.4K ﹤0.01% 2379
2022
Q1 		$101K Buy
50,344
+1,904
+4% +$3.74K ﹤0.01% 2747
2021
Q4 		$131K Buy
+48,440
New +$179K ﹤0.01% 2733

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $160M AUM 21.24% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Allspring Global Investments's CLVS Position: Q4 2022 in Review

Allspring Global Investments sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 26,156 shares — an estimated $31K sold.

Allspring Global Investments first reported a position in CLVS in Q4 2021 and held it in 4 quarters. The position peaked at $131K in Q4 2021. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • Allspring Global Investments reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • Allspring Global Investments sold 26,156 Clovis Oncology, Inc. shares in Q4 2022, an estimated $31K.
  • Allspring Global Investments first reported a position in Clovis Oncology, Inc. in Q4 2021 and held it in 4 quarters.
  • Allspring Global Investments's Clovis Oncology, Inc. position peaked at $131K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Allspring Global Investments's 13F filing for Q4 2022, filed 23 Jan 2023.